NASDAQ: NBIX - Neurocrine Biosciences

Yield per half year: +11.98%
Sector: Healthcare

Share chart Neurocrine Biosciences


About

Neurocrine Biosciences является публичной биофармацевтической компанией, основанной в 1992 году. Головной офис компании находится в Сан-Диего, штат Калифорния, и возглавляет генеральный директор Кевин Горман. Нейрокрин разрабатывает методы лечения неврологических и эндокринных заболеваний и расстройств.


Main settings

Цена ао 133.48
P/E 284.04
P/S 13.34
P/BV 16.5
EV/EBITDA 48.07
EBITDA 0.2266
Сайт http://www.neurocrine.com
Число акций ао 0.101 млрд
Выручка 0.7881
Див.доход ао 0
ISIN US64125C1099
Change price per day: 0% (134.62)
Change price per week: +1.1648% (133.07)
Change price per month: -2.79% (138.48)
Change price per 3 month: -3.26% (139.16)
Change price per half year: +11.98% (120.22)
Change price per year: +37.93% (97.6)
Change price per 3 year: +39.63% (96.41)
Change price per 5 year: +42.74% (94.31)
Change price per year to date: +1.8691% (132.15)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 13.34 1
P/BV 16.5 2
P/E 284.04 3
EV/EBITDA 48.07 3
Total:

Efficiency

Title Value Grade
ROA, % 8.89 3
ROE, % 12.68 4
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA 1.0296 8
Total:

Growth impulse

Title Value Grade
Profit growth, % 170.54 10
Share price growth, % 68.11 10
Dividend growth, % 0 0
Total:

Insider trading

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
08.02.2024 08.02.2024 ABERNETHY MATT
Chief Financial Officer
Sale 134.21 131 526 980 0 0 link
08.02.2024 08.02.2024 BENEVICH ERIC
Chief Commercial Officer
Sale 134.19 131 506 980 0 0 link
08.02.2024 08.02.2024 Gano Kyle
Chief Business Development Off
Sale 134.2 131 516 980 0 0 link
08.02.2024 08.02.2024 GORMAN KEVIN CHARLES
Chief Executive Officer
Sale 134.15 305 057 2274 0 0 link
08.02.2024 08.02.2024 Lippoldt Darin
Chief Legal Officer
Sale 134.24 122 293 911 0 0 link
06.02.2024 08.02.2024 ABERNETHY MATT
Chief Financial Officer
Sale 142.19 182 003 1280 0 0 link
06.02.2024 08.02.2024 BENEVICH ERIC
Chief Commercial Officer
Sale 142.12 181 914 1280 0 0 link
06.02.2024 08.02.2024 Gano Kyle
Chief Business Development Off
Sale 142.2 227 520 1600 0 0 link
06.02.2024 08.02.2024 GORMAN KEVIN CHARLES
Chief Executive Officer
Sale 142.18 432 227 3040 0 0 link
02.01.2024 04.01.2024 Gano Kyle
Chief Business Development Off
Sale 131.47 9 860 250 75000 0 -0.08 link
02.01.2024 04.01.2024 Gano Kyle
Chief Business Development Off
Buy 19.59 1 469 250 75000 0 0.08 link
08.12.2023 11.12.2023 ROBERTS EIRY
Chief Medical Officer
Sale 120.1 36 030 300 0 0 link
08.12.2023 11.12.2023 ROBERTS EIRY
Chief Medical Officer
Buy 81.05 24 315 300 0 0 link
07.12.2023 11.12.2023 ROBERTS EIRY
Chief Medical Officer
Sale 120.37 9 314 110 77379 0 -0.08 link
07.12.2023 11.12.2023 ROBERTS EIRY
Chief Medical Officer
Buy 78.52 6 075 800 77379 0 0.08 link
06.12.2023 08.12.2023 Lippoldt Darin
Chief Legal Officer
Sale 119.86 2 496 680 20830 0 -0.02 link
06.12.2023 08.12.2023 Lippoldt Darin
Chief Legal Officer
Buy 43.24 900 689 20830 0 0.02 link
21.08.2023 23.08.2023 ABERNETHY MATT
Chief Financial Officer
Sale 107.39 228 955 2132 0 0 link
21.08.2023 23.08.2023 BENEVICH ERIC
Chief Commercial Officer
Sale 107.4 171 840 1600 0 0 link
21.08.2023 23.08.2023 Boyer David W.
Chief Corp. Affairs Officer
Sale 107.41 171 856 1600 0 0 link
03.01.2023 05.01.2023 POPS RICHARD F
Director
Sale 119.2 1 788 000 15000 0 -0.02 link
03.01.2023 05.01.2023 POPS RICHARD F
Director
Buy 12.71 190 650 15000 0 0.02 link
03.01.2023 05.01.2023 SHERWIN STEPHEN A
Director
Sale 118.86 3 565 800 30000 0 -0.03 link
03.01.2023 05.01.2023 SHERWIN STEPHEN A
Director
Buy 12.85 385 500 30000 0 0.03 link
29.11.2022 01.12.2022 Onyia Jude
Chief Scientific Officer
Sale 121.9 284 149 2331 0 0 link
03.11.2022 04.11.2022 Cooke Julie
Chief Human Resources Officer
Sale 125 908 000 7264 0 -0.01 link
03.11.2022 04.11.2022 Cooke Julie
Chief Human Resources Officer
Buy 81.05 588 747 7264 0 0.01 link
02.11.2022 04.11.2022 Cooke Julie
Chief Human Resources Officer
Sale 124.97 142 966 1144 0 0 link
02.11.2022 04.11.2022 Cooke Julie
Chief Human Resources Officer
Buy 81.05 92 721 1144 0 0 link
26.10.2022 28.10.2022 Lippoldt Darin
Chief Legal Officer
Sale 115.02 583 957 5077 0 -0.01 link
04.10.2022 05.10.2022 LYONS GARY A
Director
Sale 110.54 552 700 5000 0 -0.01 link
03.10.2022 05.10.2022 Boyer David W.
Chief Corp. Affairs Officer
Sale 106.59 153 170 1437 0 0 link
25.04.2022 27.04.2022 LYONS GARY A
Director
Sale 92.76 1 391 400 15000 0 -0.02 link
25.04.2022 27.04.2022 LYONS GARY A
Director
Buy 6.66 99 900 15000 0 0.02 link
05.01.2022 07.01.2022 Gano Kyle
Chief Business Development Off
Sale 85.5 2 416 740 28266 0 -0.03 link
05.01.2022 07.01.2022 Gano Kyle
Chief Business Development Off
Buy 8.66 244 784 28266 0 0.03 link
12.11.2020 16.11.2020 ABERNETHY MATT
Chief Financial Officer
Sale 90.74 204 800 2257 0 0 link
12.11.2020 16.11.2020 Bozigian Haig P.
Chief Development Officer
Sale 90.74 204 800 2257 0 0 link
12.11.2020 16.11.2020 Cooke Julie
Chief Human Resources Officer
Sale 90.73 204 778 2257 0 0 link
12.11.2020 16.11.2020 Gano Kyle
Chief Business Development Off
Sale 90.73 204 778 2257 0 0 link
02.11.2020 04.11.2020 BENEVICH ERIC
Chief Commercial Officer
Sale 96.53 1 988 040 20595 0 -0.02 link
02.11.2020 04.11.2020 BENEVICH ERIC
Chief Commercial Officer
Buy 35.99 741 214 20595 0 0.02 link

Main owners

Institutions Volume Share, %
Blackrock Inc. 13647891 13.72
Vanguard Group Inc 9710328 9.76
State Street Corporation 4063336 4.08
Bellevue Group AG 2430500 2.44
Morgan Stanley 2326294 2.34
Renaissance Technologies, LLC 1988546 2
JP Morgan Chase & Company 1735543 1.74
Geode Capital Management, LLC 1623124 1.63
Janus Henderson Group PLC 1551367 1.56
Price (T.Rowe) Associates Inc 1476949 1.48

Contained in ETF

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Matthew C. Abernethy Chief Financial Officer 1.04M 1981 (43 years)
Mr. Eric S. Benevich Chief Commercial Officer 805k 1965 (59 years)
Jane Sorensen Head of Investor Relations N/A
Ms. Julie S. Cooke Chief Human Resources Officer N/A 1966 (58 years)
Dr. Kevin C. Gorman Ph.D. CEO & Director 1.9M 1958 (66 years)
Dr. Jude Onyia Ph.D. Chief Scientific Officer 621.66k 1965 (59 years)
Dr. Eiry Wyn Roberts M.D. Chief Medical Officer 1.04M 1965 (59 years)
Mr. Darin M. Lippoldt Esq. Chief Legal Officer & Corporate Secretary 921.01k 1966 (58 years)
Mr. Kyle W. Gano Ph.D. Chief Business Development & Strategy Officer 921.52k 1973 (51 year)
Mr. David Warren Boyer Chief Corporate Affairs Officer N/A 1980 (44 years)

About company

Address: United States, San Diego, CA , 12780 El Camino Real - open in Google maps, open in Yandex maps
Website: http://www.neurocrine.com